Alignment Healthcare, Inc.
NASDAQ:ALHC
12.97 (USD) • At close August 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,015.288 | 926.932 | 701.241 | 692.433 | 681.286 | 628.601 | 465.387 | 456.709 | 462.379 | 439.155 | 361.811 | 360.348 | 366.474 | 345.526 | 298.274 | 293.466 | 308.951 | 267.082 | 242.409 | 247.867 | 244.313 | 224.633 |
| Cost of Revenue
| 0 | 820.9 | 614.896 | 613.444 | 605.312 | 573.218 | 417.762 | 397.879 | 410.644 | 396.315 | 326.002 | 312.85 | 307.269 | 303.758 | 259.571 | 253.99 | 274.385 | 251.095 | 215.014 | 190.08 | 194.502 | 193.396 |
| Gross Profit
| 0 | 106.032 | 86.345 | 78.989 | 75.974 | 55.383 | 47.625 | 58.83 | 51.735 | 42.84 | 35.809 | 47.498 | 59.205 | 41.768 | 38.703 | 39.476 | 34.566 | 15.987 | 27.395 | 57.787 | 49.811 | 31.237 |
| Gross Profit Ratio
| 0 | 0.114 | 0.123 | 0.114 | 0.112 | 0.088 | 0.102 | 0.129 | 0.112 | 0.098 | 0.099 | 0.132 | 0.162 | 0.121 | 0.13 | 0.135 | 0.112 | 0.06 | 0.113 | 0.233 | 0.204 | 0.139 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 76.781 | 0 | 0 | 0 | 75.27 | 0 | 0 | 0 | 74.5 | 0 | 0 | 0 | 49.614 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 6.956 | 0 | 0 | 0 | 7.958 | 0 | 0 | 0 | 3.581 | 0 | 0 | 0 | 1.505 | 0 | 0 | 0 |
| SG&A
| 103.797 | 103.831 | 102.128 | 90.871 | 87.863 | 90.512 | 83.737 | 83.089 | 70.199 | 70.408 | 83.228 | 76.452 | 61.673 | 74.293 | 78.081 | 76.846 | 71.15 | 64.914 | 51.119 | 38.794 | 33.698 | 32.787 |
| Other Expenses
| 0 | 7.594 | 6.762 | 7.64 | -94.356 | -96.489 | 0.142 | 0.145 | 0.428 | 4.921 | 4.687 | 4.456 | 4.18 | 3.95 | 0.084 | 0.048 | 0.059 | 0.038 | 0.038 | 0.057 | -0.03 | -0.797 |
| Operating Expenses
| 103.797 | 111.425 | 102.128 | 98.511 | 94.356 | 96.489 | 89.538 | 88.586 | 75.394 | 75.329 | 87.915 | 80.908 | 65.853 | 78.243 | 82.169 | 80.926 | 75.058 | 68.651 | 55.19 | 42.727 | 37.224 | 36.352 |
| Operating Income
| 22.748 | -5.393 | -22.545 | -19.522 | -18.382 | -41.106 | -41.913 | -29.756 | -23.659 | -32.489 | -52.106 | -33.41 | -6.648 | -36.475 | -43.466 | -41.45 | -40.492 | -52.664 | -27.795 | 15.06 | 12.587 | -5.115 |
| Operating Income Ratio
| 0.022 | -0.006 | -0.032 | -0.028 | -0.027 | -0.065 | -0.09 | -0.065 | -0.051 | -0.074 | -0.144 | -0.093 | -0.018 | -0.106 | -0.146 | -0.141 | -0.131 | -0.197 | -0.115 | 0.061 | 0.052 | -0.023 |
| Total Other Income Expenses Net
| -3.871 | -3.94 | -8.512 | -6.915 | -5.599 | -5.469 | -5.342 | -5.321 | -4.834 | -4.881 | -4.717 | -6.67 | -4.932 | -4.342 | -4.368 | -4.366 | -4.27 | -4.21 | -3.371 | -4.214 | -4.222 | -4.957 |
| Income Before Tax
| 18.877 | -9.333 | -31.057 | -26.437 | -23.981 | -46.575 | -47.255 | -35.077 | -28.493 | -37.37 | -56.823 | -40.08 | -11.58 | -40.817 | -47.834 | -45.816 | -44.762 | -56.874 | -32.065 | 10.846 | 8.365 | -10.072 |
| Income Before Tax Ratio
| 0.019 | -0.01 | -0.044 | -0.038 | -0.035 | -0.074 | -0.102 | -0.077 | -0.062 | -0.085 | -0.157 | -0.111 | -0.032 | -0.118 | -0.16 | -0.156 | -0.145 | -0.213 | -0.132 | 0.044 | 0.034 | -0.045 |
| Income Tax Expense
| 3.224 | 0.021 | 0.007 | -0.008 | 0.022 | -0.054 | -0.024 | -0.03 | 0.001 | 0.001 | 0.172 | 0.167 | 4.932 | 4.342 | 0 | 0 | 0 | 0 | 4.346 | 0 | 0 | 0 |
| Net Income
| 15.667 | -9.114 | -31.091 | -26.413 | -24.01 | -46.521 | -47.209 | -35.047 | -28.477 | -37.371 | -56.995 | -40.247 | -16.512 | -45.159 | -47.834 | -45.816 | -44.762 | -56.874 | -32.065 | 10.846 | 8.365 | -10.072 |
| Net Income Ratio
| 0.015 | -0.01 | -0.044 | -0.038 | -0.035 | -0.074 | -0.101 | -0.077 | -0.062 | -0.085 | -0.158 | -0.112 | -0.045 | -0.131 | -0.16 | -0.156 | -0.145 | -0.213 | -0.132 | 0.044 | 0.034 | -0.045 |
| EPS
| 0.08 | -0.05 | -0.16 | -0.14 | -0.13 | -0.25 | -0.25 | -0.19 | -0.15 | -0.2 | -0.31 | -0.22 | -0.091 | -0.25 | -0.27 | -0.26 | -0.25 | -0.37 | -0.21 | 0.071 | 0.055 | -0.066 |
| EPS Diluted
| 0.07 | -0.05 | -0.16 | -0.14 | -0.13 | -0.25 | -0.25 | -0.19 | -0.15 | -0.2 | -0.31 | -0.22 | -0.091 | -0.25 | -0.27 | -0.26 | -0.25 | -0.37 | -0.21 | 0.071 | 0.055 | -0.066 |
| EBITDA
| 29.844 | 2.244 | -18.92 | -11.814 | -11.751 | -35.119 | -35.91 | -24.05 | -17.967 | -27.369 | -47.279 | -30.962 | -2.861 | -32.423 | -39.233 | -37.269 | -36.471 | -48.837 | -22.787 | 19.137 | 16.171 | -2.84 |
| EBITDA Ratio
| 0.029 | 0.002 | -0.027 | -0.017 | -0.017 | -0.056 | -0.077 | -0.053 | -0.039 | -0.062 | -0.131 | -0.086 | -0.008 | -0.094 | -0.132 | -0.127 | -0.118 | -0.183 | -0.094 | 0.077 | 0.066 | -0.013 |